Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Auditory Perception in Individuals with Friedreich's Ataxia
Audiology & Neuro-Otology, 11/05/09
Rance G et al. – The results suggest that auditory pathway abnormality is a relatively common consequence of FRDA. Regular auditory evaluation should therefore be part of the management regime for all affected individuals. This assessment should include both ABR testing, which can provide insights into the degree to which auditory neural activity is disrupted, and some functional measure of hearing capacity such as speech perception assessment, which can quantify the disorder and provide a basis for intervention.
Related Articles
Lundbeck starts clinical phase IIa with Lu AA24493 in Friedreich's ataxia in a study also assessing efficacy via biomarkers
Lundbeck, 11/03/09
Relevance Score: 66%
Physiologic Alterations in Ataxia
Archives of Neurology, 10/19/09
Relevance Score: 45%
Antioxidants and other pharmacological treatments for Friedreich ataxia
Cochrane Reviews, 10/09/09
Relevance Score: 45%
Extracerebellar MRI—Lesions in Ataxia Telangiectasia Go Along with Deficiency of the GH/IGF-1 Axis, Markedly Reduced Body Weight, High Ataxia Scores and Advanced Age
The Cerebellum, 11/12/09
Relevance Score: 44%
Isolated ataxia after pure left insular cortex infarction
Neurological Sciences, 10/20/09
Relevance Score: 44%
Today in ENT...keeping you current
Receive free subspecialty "5-minute updates" via email
Early Prediction of Response to Chemoradiotherapy for Head and Neck Cancer
Archives of Otolaryngology, 11/25/09
N2 Disease in Patients With Head and Neck Squamous Cell Cancer Treated With Chemoradiotherapy
Archives of Otolaryngology, 11/25/09
Laser-induced thermal therapy and cisplatin for recurrent head and neck cancer: A case characterized by an unusually long disease-free survival
ENT Journal, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


